Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lemborexant - Eisai

Drug Profile

Lemborexant - Eisai

Alternative Names: DAYVIGO; E-2006

Latest Information Update: 13 Jan 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eisai Inc
  • Class Cyclopropanes; Hypnosedatives; Pyridines; Pyrimidines; Sleep disorder therapies; Small molecules
  • Mechanism of Action Orexin receptor type 1 antagonists; Orexin receptor type 2 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Registered Insomnia
  • Phase II Circadian rhythm sleep disorders
  • Phase I Sleep apnoea syndrome

Most Recent Events

  • 27 Dec 2019 Adverse events data from phase III SUNRISE 1 trial in Insomnia released by Eisai
  • 23 Dec 2019 Registered for Insomnia in USA (PO)-first global approval
  • 23 Dec 2019 Pooled efficacy data from the SUNRISE 2 and SUNRISE 1 trial in Insomnia released by Eisai
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top